MRI引导下穿刺与融合穿刺在前列腺癌Gleason分级一致性中的比较
本研究回顾性纳入191例接受靶向穿刺后行根治性前列腺切除术的患者,比较MRI引导下穿刺与MRI-经直肠超声融合穿刺的Gleason分级一致性。
要点
- 多数分级误分类为GG2与GG3之间的互换(占56%)。
诊断标准与关键数值
- 在77例被两种穿刺技术误分类的患者中,56%(43例)为GG2与GG3之间的互换。
临床应用与阅片要点
- 对于计划行靶向穿刺的前列腺癌患者,选择MRI引导下穿刺可能降低术后Gleason分级升级的风险,有助于更准确的风险分层。
- 报告穿刺病理Gleason分级时,应意识到融合穿刺存在较高的分级升级可能,尤其对于GG2-3患者需谨慎解读。
局限性
- 回顾性研究设计。
- 单中心研究,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine and compare rates of grade group (GG) discrepancies between different targeted biopsy techniques (in-bore vs fusion) after propensity score weighting using whole-mount radical prostatectomy (RP) histopathologic analysis as the reference standard.
MATERIALS AND METHODS: This retrospective study evaluated men who underwent targeted (fusion or in-bore) biopsy between April 2017 and January 2019 followed by prostatectomy. The primary endpoint of the study was a change in GG from biopsy to RP at a patient level. For downgrade and upgrade analysis, men with biopsy GG1 (downgrade not possible) and GG5 (upgrade not possible) were excluded, respectively. GG upgrade, downgrade, and concordance rates of each targeting approach were compared using propensity score weighting and logistic regression with inverse probability of treatment weighting. Significance level was set at .05. Index lesion GG on RP specimen served as the reference standard.
RESULTS: A total of 191 men (90 in the in-bore [mean age, 63 years ± 7 (standard deviation)] and 101 in the fusion biopsy group [mean age, 65 years ± 7]) were eligible and included. Fewer GG upgrades were noted in the in-bore biopsy group (14%; 12 of 85) compared with the fusion plus systematic biopsy group (30%; 28 of 93) (P = .012). The incidence of GG downgrade in the in-bore group (25%; 21 of 84) was higher than in the fusion group (17%; 16 of 93); however, the difference was not statistically significant (P = .2). Of the 77 men misclassified by both biopsy techniques, the majority (56%, n = 43) had a change in GG of 2 to 3 or 3 to 2.
CONCLUSION: Superior sampling accuracy with MRI-guided in-bore biopsies offers a lower incidence of GG upgrades compared with MRI-transrectal US fusion biopsies upon RP.Keywords: Biopsy/Needle Aspiration, MR-Imaging, Oncology, Pathology, Prostate Supplemental material is available for this article.© RSNA, 2021.
引用
- Costa DN, Cai Q, Xi Y, et al. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies. Radiol Imaging Cancer. 2021. PMID: 33817652. doi:10.1148/rycan.2021200123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。